NCT03625817
- Conditions
- Body Temperature Changes, Metabolic Disturbance, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- Cyprus International Institute of Environmental and Public Health Limassol, Cyprus
Clinical trial condition
Metabolic Disturbance
Explore clinical trials studying Metabolic Disturbance. Study availability and eligibility vary by location and protocol.
50 public trials
7 recruiting studies
Metabolic Disturbance trial results
NCT03502304
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +11 more
- Locations
-
- Cristian Alvarez Los Lagos, Osorno, Chile
Completed
Blueberries, Bananas, Exercise Recovery
NCT03445234
- Conditions
- Behavior, Immune Suppression, Inflammation, +5 more
- Locations
-
- North Carolina Research Campus, Human Performance Lab Kannapolis, North Carolina, United States
NCT02689882
- Conditions
- Metabolic Disturbance
- Locations
-
- University of Washington Seattle, Washington, United States
NCT03313869
- Conditions
- Behavior, Glucose Intolerance, Glucose Metabolism Disorders, +8 more
- Locations
-
- Medes-Imps Toulouse, France
NCT01674426
- Conditions
- Behavior, Behavioral Symptoms, Disorder of Endocrine Ovary, +3 more
- Locations
-
- UPittsburgh Pittsburgh, Pennsylvania, United States
NCT02246296
- Conditions
- Body Weight, Body Weight Changes, Cachexia, +13 more
- Locations
-
- Kilifi County Hospital Kilifi, Coast, Kenya
- Coast Provincial General Hospital - Study site Mombasa, Kenya
- Queen Elizabeth Hospital- Study site Blantyre, Malawi
Active, Not Recruiting
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
NCT04469790
- Conditions
- Affect, Anxiety, Anxiety Disorders, +6 more
- Locations
-
- Britni Ryan Belcher, PhD, MPH Los Angeles, California, United States
Active, Not Recruiting
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
NCT04528004
- Conditions
- Cardiovascular Diseases, Heart Diseases, Heart Failure, +3 more
- Locations
-
- University of Washington Seattle, Washington, United States
Active, Not Recruiting
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
NCT04892199
- Conditions
- Clozapine, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Psychosis Research Unit, Aarhus University Hospital, Psychiatry, Aarhus, Denmark
- Psychiatric Centre Copenhagen, Rigshospitalet Copenhagen, Denmark
- Psychiatric Centre Nordsjaelland, Hillerød Hillerød, Denmark